Asthma Associated with Lower COVID-19 Mortality 

The Journal of Allergy or Clinical Immunology: In Practice released an article in its November 2023 edition comparing ”in-hospital COVID-19 outcomes among patients with asthma, COPD, and no airway disease.” Researchers conducted a retrospective cohort study on patients admitted with COVID-19 by creating scores for mortality and sequential organ failure assessments and then compared the groups. They found “COVID-19 severity was increased in patients with COPD and decreased in those with asthma, eosinophilia, and noneosinophilic asthma, independent of clinical confounders.” They noted that “COVID-19 severity may be influenced by intrinsic immunological factors in patients with airway diseases, such as type 2 inflammation.” 

For an article examining the study, click here

To view the study, click here.